COPS3 and osteosarcoma: Our previous study demonstrated that the frequency of COPS3 overexpression was significantly higher in osteosarcoma patients with metastasis than in patients without metastasis, and COPS3 silencing decreased the migration ability of osteosarcoma cells [4].